| Autor: |
Ranjit Mohan Anjana, Nadiminty Ganapathi Sastry, Muthu Ramuu, Prasanna Kumar Gupta, Jaggi Shalini, Brijendra Kumar Srivastava, Chaithanya Murthy Kocherlakota, Tata Sameer Nandan, Gangadhara Praveen, Jyotish Nair, Routray Philips, Viswanathan Mohan, Ranjit Unnikrishnan |
| Jazyk: |
angličtina |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Journal of Diabetology, Vol 11, Iss 2, Pp 65-70 (2020) |
| Druh dokumentu: |
article |
| ISSN: |
2078-7685 |
| DOI: |
10.4103/JOD.JOD_33_20 |
| Popis: |
Hydroxychloroquine (HCQ) is a drug, which has long been used in the treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren’s syndrome. Recently with the COVID-19 pandemic hitting the world, there have been studies suggesting that hydroxychloroquine may be useful both in the prevention and the treatment of COVID-19, although the evidence so far has been conflicting. This article reviews the available evidence for the use of hydroxychloroquine in COVID-19 and also mentions some of the ongoing trials in this field. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
